IL155699A0 - Neutral and anionic colloidal particles for gene delivery - Google Patents
Neutral and anionic colloidal particles for gene deliveryInfo
- Publication number
- IL155699A0 IL155699A0 IL15569901A IL15569901A IL155699A0 IL 155699 A0 IL155699 A0 IL 155699A0 IL 15569901 A IL15569901 A IL 15569901A IL 15569901 A IL15569901 A IL 15569901A IL 155699 A0 IL155699 A0 IL 155699A0
- Authority
- IL
- Israel
- Prior art keywords
- neutral
- gene delivery
- colloidal particles
- anionic colloidal
- anionic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25382700P | 2000-11-29 | 2000-11-29 | |
| GB0105346A GB0105346D0 (en) | 2000-11-29 | 2001-03-05 | Neutral and anionic colloidal particles for gene delivery |
| PCT/EP2001/013800 WO2002043769A2 (en) | 2000-11-29 | 2001-11-27 | Neutral and anionic colloidal particles for gene delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL155699A0 true IL155699A0 (en) | 2003-11-23 |
Family
ID=26245779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15569901A IL155699A0 (en) | 2000-11-29 | 2001-11-27 | Neutral and anionic colloidal particles for gene delivery |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1370295A2 (en) |
| JP (1) | JP2004520288A (en) |
| AU (1) | AU2073002A (en) |
| CA (1) | CA2429803A1 (en) |
| IL (1) | IL155699A0 (en) |
| WO (1) | WO2002043769A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05010499A (en) * | 2003-03-31 | 2006-05-25 | Johnson & Johnson | Lipid particles having asymmetric lipid coating and method of preparing same. |
| US8969543B2 (en) | 2003-04-03 | 2015-03-03 | Bioneer Corporation | SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof |
| WO2004087931A1 (en) * | 2003-04-03 | 2004-10-14 | Korea Advanced Institute Of Science And Technology | Conjugate for gene transfer comprising oligonucleotide and hydrophilic polymer, polyelectrolyte complex micelles formed from the conjugate, and methods for preparation thereof |
| WO2008005479A2 (en) * | 2006-07-06 | 2008-01-10 | University Of Wyoming | Charge reversible polymers |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2264140A1 (en) * | 1996-08-26 | 1998-03-05 | Transgene S.A. | Cationic lipid-nucleic acid complexes |
| FR2763943B1 (en) * | 1997-05-28 | 1999-07-09 | Rhone Poulenc Rorer Sa | COMPOUNDS, THEIR PREPARATION AND THEIR USE FOR TRANSFERRING NUCLEIC ACIDS INTO CELLS |
-
2001
- 2001-11-27 JP JP2002545739A patent/JP2004520288A/en not_active Withdrawn
- 2001-11-27 EP EP01998364A patent/EP1370295A2/en not_active Ceased
- 2001-11-27 CA CA002429803A patent/CA2429803A1/en not_active Abandoned
- 2001-11-27 IL IL15569901A patent/IL155699A0/en unknown
- 2001-11-27 AU AU2073002A patent/AU2073002A/en not_active Withdrawn
- 2001-11-27 WO PCT/EP2001/013800 patent/WO2002043769A2/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002043769A3 (en) | 2003-10-09 |
| CA2429803A1 (en) | 2002-06-06 |
| WO2002043769A2 (en) | 2002-06-06 |
| EP1370295A2 (en) | 2003-12-17 |
| JP2004520288A (en) | 2004-07-08 |
| AU2073002A (en) | 2002-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002235283A1 (en) | Electronically controlled vehicle lift and vehicle service system | |
| AU2001255467A1 (en) | Security systems for delivering goods and services | |
| AU2001245384A1 (en) | Delivery system and method for vehicles and the like | |
| AU2001294922A1 (en) | Automated bioculture and bioculture experiments system | |
| GB0005268D0 (en) | Document creation and delivery | |
| GB0014759D0 (en) | Service delivery method and system | |
| AU2001283225A1 (en) | Heating and dispensing system for fluids | |
| AU2002218556A1 (en) | 3 dimensional slab rendering system, method and computer-readable medium | |
| AU4668601A (en) | Microprojectile delivery system and particulate product | |
| AU2002243249A1 (en) | User configurable demand deposit account system and method | |
| AU2001296014A1 (en) | Agents for recoverying from or preventing fatigue in the central nerve system and foods for recoverying from or preventing fatigue | |
| AU4506101A (en) | Demand aggregation and distribution system | |
| AU2002210823A1 (en) | Connection of service lines in tractor-trailer vehicles | |
| AUPQ926600A0 (en) | Improvements in fluid delivery systems | |
| AU2001238485A1 (en) | Methods and compositions for gene delivery | |
| AU2002360507A1 (en) | System and method for electronically delivering documents | |
| IL155699A0 (en) | Neutral and anionic colloidal particles for gene delivery | |
| AU2001297738A1 (en) | Gene delivery device and gene delivery method | |
| AU2001264852A1 (en) | Lactobacillusbeta -glucuronidase and dna encoding the same | |
| GB0105346D0 (en) | Neutral and anionic colloidal particles for gene delivery | |
| AU2002319742A1 (en) | System for dispersing one fluid in another | |
| AU2000234571A1 (en) | Gift certificate distribution managing method and gift certificate | |
| HK1059042A1 (en) | Topical micronutrient delivery system and uses thereof | |
| AU2001284037A1 (en) | Magnetites that are low in silicon | |
| AU2001213286A1 (en) | Multi-valve delivery system |